JP2020518676A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518676A5 JP2020518676A5 JP2020511873A JP2020511873A JP2020518676A5 JP 2020518676 A5 JP2020518676 A5 JP 2020518676A5 JP 2020511873 A JP2020511873 A JP 2020511873A JP 2020511873 A JP2020511873 A JP 2020511873A JP 2020518676 A5 JP2020518676 A5 JP 2020518676A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- iii
- hind
- weight percentage
- weight percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022186393A JP7433402B2 (ja) | 2017-05-05 | 2022-11-22 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2024016340A JP7698083B2 (ja) | 2017-05-05 | 2024-02-06 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2025098540A JP2025123344A (ja) | 2017-05-05 | 2025-06-12 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501984P | 2017-05-05 | 2017-05-05 | |
| US62/501,984 | 2017-05-05 | ||
| PCT/US2018/031436 WO2018204930A1 (en) | 2017-05-05 | 2018-05-07 | Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022186393A Division JP7433402B2 (ja) | 2017-05-05 | 2022-11-22 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020518676A JP2020518676A (ja) | 2020-06-25 |
| JP2020518676A5 true JP2020518676A5 (https=) | 2021-07-26 |
| JP7183253B2 JP7183253B2 (ja) | 2022-12-05 |
Family
ID=64016742
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511873A Active JP7183253B2 (ja) | 2017-05-05 | 2018-05-07 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2022186393A Active JP7433402B2 (ja) | 2017-05-05 | 2022-11-22 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2024016340A Active JP7698083B2 (ja) | 2017-05-05 | 2024-02-06 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2025098540A Pending JP2025123344A (ja) | 2017-05-05 | 2025-06-12 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022186393A Active JP7433402B2 (ja) | 2017-05-05 | 2022-11-22 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2024016340A Active JP7698083B2 (ja) | 2017-05-05 | 2024-02-06 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
| JP2025098540A Pending JP2025123344A (ja) | 2017-05-05 | 2025-06-12 | トランス－［テトラクロロビス（１ｈ－インダゾール）ルテニウム酸（ｉｉｉ）］及びその組成物の製造 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US10611787B2 (https=) |
| EP (3) | EP4245305B1 (https=) |
| JP (4) | JP7183253B2 (https=) |
| CN (2) | CN117462558A (https=) |
| AU (2) | AU2018263965B2 (https=) |
| CA (1) | CA3062369A1 (https=) |
| ES (1) | ES2959891T3 (https=) |
| PL (1) | PL3618827T3 (https=) |
| RU (1) | RU2019138773A (https=) |
| SG (1) | SG11201910043PA (https=) |
| WO (1) | WO2018204930A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201910043PA (en) | 2017-05-05 | 2019-11-28 | Intezyne Technologies Inc | Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof |
| WO2021108923A1 (en) * | 2019-12-05 | 2021-06-10 | Bold Therapeutics Inc. | Combined use of sodium trans-[tetrachloridobis(1h-indazole)ruthenate(iii)] and etomoxir for treating cancers |
| WO2021195763A1 (en) * | 2020-03-30 | 2021-10-07 | Bold Therapeutics Inc. | Antiviral ruthenate(iii) therapeutics |
| EP4247413A4 (en) * | 2020-11-18 | 2024-10-09 | Bold Therapeutics Inc. | USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCERS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19612291A1 (de) * | 1996-03-28 | 1997-10-02 | Bernhard K Prof Dr Dr Keppler | Arzneimittelzubereitungen enthaltend tumorhemmend wirkende Ruthenium(III)-Komplexe |
| DE10103565B4 (de) * | 2001-01-26 | 2007-06-14 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus |
| JP5296063B2 (ja) * | 2007-06-11 | 2013-09-25 | ニッキ ファーマ インク． | ルテニウム錯体を製造する方法 |
| WO2011161570A2 (en) * | 2010-06-22 | 2011-12-29 | Firmenich Sa | Ruthenium based complexes |
| WO2012012305A2 (en) | 2010-07-18 | 2012-01-26 | Niiki Pharma Inc. | Combination therapy using a ruthenium complex |
| BR112015023568B8 (pt) | 2013-03-15 | 2024-01-02 | Ann Mcfarland Sherri | Composto à base de metal como composto fotodinâmico |
| CN103601759B (zh) * | 2013-10-18 | 2015-08-19 | 武汉利宝瑞医药科技有限公司 | 一种用于治疗肿瘤的钌(iii)络合物的制备方法 |
| EP3313392B1 (en) | 2015-06-23 | 2020-09-16 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| SG11201910043PA (en) * | 2017-05-05 | 2019-11-28 | Intezyne Technologies Inc | Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof |
-
2018
- 2018-05-07 SG SG11201910043P patent/SG11201910043PA/en unknown
- 2018-05-07 EP EP23186755.7A patent/EP4245305B1/en active Active
- 2018-05-07 CN CN202311350513.0A patent/CN117462558A/zh active Pending
- 2018-05-07 PL PL18794220.6T patent/PL3618827T3/pl unknown
- 2018-05-07 CN CN201880043453.9A patent/CN111372939B/zh active Active
- 2018-05-07 AU AU2018263965A patent/AU2018263965B2/en active Active
- 2018-05-07 RU RU2019138773A patent/RU2019138773A/ru unknown
- 2018-05-07 JP JP2020511873A patent/JP7183253B2/ja active Active
- 2018-05-07 EP EP18794220.6A patent/EP3618827B1/en active Active
- 2018-05-07 ES ES18794220T patent/ES2959891T3/es active Active
- 2018-05-07 US US15/973,370 patent/US10611787B2/en active Active
- 2018-05-07 WO PCT/US2018/031436 patent/WO2018204930A1/en not_active Ceased
- 2018-05-07 CA CA3062369A patent/CA3062369A1/en active Pending
- 2018-05-07 EP EP25200214.2A patent/EP4635503A3/en active Pending
-
2020
- 2020-02-04 US US16/781,060 patent/US11040993B2/en active Active
-
2021
- 2021-05-26 US US17/330,822 patent/US11739111B2/en active Active
-
2022
- 2022-11-22 JP JP2022186393A patent/JP7433402B2/ja active Active
-
2023
- 2023-07-20 US US18/355,945 patent/US12415825B2/en active Active
-
2024
- 2024-02-06 JP JP2024016340A patent/JP7698083B2/ja active Active
- 2024-05-27 AU AU2024203511A patent/AU2024203511B2/en active Active
-
2025
- 2025-06-12 JP JP2025098540A patent/JP2025123344A/ja active Pending
- 2025-07-23 US US19/277,690 patent/US20260042792A1/en active Pending